Facebook post by University of Helsinki

Tumour DNA circulating in the bloodstream of patients with aggressive lymphoma can help to monitor how well treatments are working.
Researchers discover new tools in regular blood samples for developing precision therapies for lymphoma | University of Helsinki www.helsinki.fi

Tumour DNA circulating in the bloodstream of patients with aggressive lymphoma has a previously unknown and even crucial role in the identification of effective therapies for this serious disease.